Clinical trials
Phase 3 Acromegaly trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 4 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Terminated | 6 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ipsen | 7 |
| Novartis Pharmaceuticals | 5 |
| Ambrilia Biopharma, Inc. | 3 |
| Chiasma, Inc. | 3 |
| Camurus AB | 2 |
| Crinetics Pharmaceuticals Inc. | 2 |
| Endo USA Inc., a Keenova Therapeutics Company | 2 |
| Debiopharm International SA | 1 |
| Göteborg University | 1 |
| National Institute of Dental and Craniofacial Research (NIDCR) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acromegaly | 32 |
| Pituitary Neoplasms | 5 |
| Pituitary Diseases | 3 |
| Adenoma | 2 |
| Gigantism | 2 |
| Growth Hormone-Secreting Pituitary Adenoma | 2 |
| Fibrous Dysplasia, Polyostotic | 1 |
| Growth Disorders | 1 |
| Hyperplasia | 1 |
| Pituitary ACTH Hypersecretion | 1 |
Trials
Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.